Arkolith/Insider Trading/FACT/Form 4

Goodwin Bradford S

DirectorFACET BIOTECH CORP (FACT) · full profile →Form 4 · filed Apr 23, 2010
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2010Disposed to issuer(D)3K$27.00$90K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 21, 2010Disposed to issuer(D)7K$27.00$180K0
Apr 21, 2010Disposed to issuer(D)20K$27.00$540K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001441848-10-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for FACET BIOTECH CORP

Build

Ask your agent about FACT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001441848-10-000017"
Ask your agent
Use Arkolith to summarize insider buying and selling at FACET BIOTECH CORP
over the last 90 days and cite the filings.